Clinical Trials at New York Cancer and Blood Specialists
As of July 2026, 11 paid clinical trials are recruiting at New York Cancer and Blood Specialists in Shirley, New York. Active studies at this site cover conditions such as Colorectal Neoplasms, Carcinoma, Non-Small-Cell Lung and Esophageal Adenocarcinoma. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
11 clinical trials at New York Cancer and Blood Specialists
·Clear filters·A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC)
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer
A Study of BGB-16673 Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors
A Dose Escalation Study of AV-380 in Cancer Patients With Cachexia
Common conditions studied in Shirley
- Colorectal Neoplasms (3 active studies)
- Carcinoma, Non-Small-Cell Lung (2 active studies)
- Esophageal Adenocarcinoma (2 active studies)
- Gastroesophageal Junction Adenocarcinoma (2 active studies)
- Adenocarcinoma (1 active study)
- Breast Neoplasms (1 active study)
Leading research sponsors in Shirley
- Janssen Research & Development, LLC
- Bristol-Myers Squibb
- Eli Lilly and Company
- AVEO Pharmaceuticals, Inc.
- AbbVie
Frequently asked questions
How many paid clinical trials are currently recruiting in Shirley?
There are approximately 24 recruiting clinical trials in Shirley, New York listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Shirley pay participants?
Most recruiting trials in Shirley compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Shirley?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Shirley?
The most common conditions under active study in Shirley include Colorectal Neoplasms (3), Carcinoma, Non-Small-Cell Lung (2), Esophageal Adenocarcinoma (2), Gastroesophageal Junction Adenocarcinoma (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Shirley?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Shirley on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Shirley?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Shirley?
Recruiting research sites in Shirley include New York Cancer and Blood Specialists, North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists, NY Cancer and Blood Specialists, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Shirley right now?
The largest active categories in Shirley are Cancer & tumors (14), Eye & vision (1). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.